Eclypsium
Provides supply chain security for IT infrastructure
$25MSeries C+
Role not disclosedSD
Sixty Degree Capital
Activity from announced rounds
Activity in this selectionUnited States · Oct 23, 2026 · Jan 1, 2026
- Rounds participated in
- 5
- Confirmed lead rounds
- — 5 roles undisclosed
- New companies
- 5 First participation on record · 0 follow-on
- Funding in participating rounds
- $533M 5 disclosed · full round size, not this investor’s share
By stage
By primary sector
By country
Rounds
5 in this selectionCrossbow Therapeutics
Crossbow Therapeutics develops antibody therapies for cancer.
$77MSeries B
Role not disclosedHawkEye 360
Detects, geolocates, and characterizes RF signals using a commercial satellite constellation
$23MSeries E
Role not disclosedKinaset Therapeutics
Develops inhaled therapies for severe respiratory diseases
$103MSeries B
Role not disclosedParabilis Medicines
Develops medicines targeting historically undruggable protein targets in cancer
$305MSeries F
Role not disclosed